ATE140213T1 - N-monosubstituierte cyclopentenylamine, ein verfahren zu ihrer herstellung, und ihre verwendung als medikament - Google Patents
N-monosubstituierte cyclopentenylamine, ein verfahren zu ihrer herstellung, und ihre verwendung als medikamentInfo
- Publication number
- ATE140213T1 ATE140213T1 AT91103350T AT91103350T ATE140213T1 AT E140213 T1 ATE140213 T1 AT E140213T1 AT 91103350 T AT91103350 T AT 91103350T AT 91103350 T AT91103350 T AT 91103350T AT E140213 T1 ATE140213 T1 AT E140213T1
- Authority
- AT
- Austria
- Prior art keywords
- cyclopentenylamines
- monosubstituted
- medication
- production
- medicaments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/25—Sulfonic acids having sulfo groups bound to carbon atoms of rings other than six-membered aromatic rings of a carbon skeleton
- C07C309/26—Sulfonic acids having sulfo groups bound to carbon atoms of rings other than six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/40—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing only non-condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- External Artificial Organs (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909005247A GB9005247D0 (en) | 1990-03-08 | 1990-03-08 | A novel substituted-amine compound and a process for the preparation thereof |
GB909021806A GB9021806D0 (en) | 1990-10-08 | 1990-10-08 | A novel substituted-amine compound and a process for the preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE140213T1 true ATE140213T1 (de) | 1996-07-15 |
Family
ID=26296763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91103350T ATE140213T1 (de) | 1990-03-08 | 1991-03-06 | N-monosubstituierte cyclopentenylamine, ein verfahren zu ihrer herstellung, und ihre verwendung als medikament |
Country Status (14)
Country | Link |
---|---|
US (1) | US5256824A (de) |
EP (1) | EP0445749B1 (de) |
JP (1) | JPH0819058B2 (de) |
KR (1) | KR910016691A (de) |
CN (1) | CN1054586A (de) |
AT (1) | ATE140213T1 (de) |
AU (1) | AU645062B2 (de) |
CA (1) | CA2037721A1 (de) |
DE (1) | DE69120699T2 (de) |
FI (1) | FI911138A (de) |
HU (2) | HUT60710A (de) |
IE (1) | IE910752A1 (de) |
NO (1) | NO175679C (de) |
PT (1) | PT96967A (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4028046A1 (de) * | 1990-09-05 | 1992-03-12 | Bayer Ag | Arzneimittel enthaltend substituierte 2-cyclohexen-1-yl-amin-derivate und ihre verwendung zur bekaempfung von krankheiten |
EP0789575B8 (de) * | 1994-11-02 | 2009-01-14 | Allelix Neuroscience, Inc. | Natrium-ionenkanäle spezifisch für das periphäre nervensystem, dna welche diese kodiert, wirkstoff-suche und methoden zu deren herstellung und verwendung |
WO1998011888A1 (en) * | 1996-09-19 | 1998-03-26 | American Home Products Corporation | Method of treating urinary incontinence |
AU4290099A (en) * | 1998-06-29 | 2000-01-17 | Mitsubishi-Tokyo Pharmaceuticals, Inc. | Process for the preparation of optically active trans-cyclohexylamine compounds |
DE29923134U1 (de) * | 1999-11-16 | 2000-06-29 | Sanol Arznei Schwarz Gmbh | Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen |
DE10332486A1 (de) * | 2003-07-16 | 2005-02-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung akuter Schmerzen |
WO2007073792A1 (de) * | 2005-12-19 | 2007-07-05 | Bayer Schering Pharma Aktiengesellschaft | Verfahren zur herstellung von 4,4-diphenylcyclohexanol |
DE102012106955B4 (de) * | 2012-07-31 | 2014-04-03 | Netzsch-Gerätebau GmbH | Vorrichtung und Verfahren zur photothermischen Untersuchung einer Probe |
WO2020205867A1 (en) | 2019-04-02 | 2020-10-08 | Aligos Therapeutics, Inc. | Compounds targeting prmt5 |
CN110963877B (zh) * | 2019-12-18 | 2022-10-04 | 河北旭阳能源有限公司 | 1-氯-1-氯乙酰基环丙烷的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3285960A (en) * | 1964-01-14 | 1966-11-15 | Cutter Lab | 4, 4-diphenylcyclohexylamine derivatives |
GB1102428A (en) * | 1964-10-26 | 1968-02-07 | Ciba Ltd | Cycloaliphatic amines and process for their manufacture |
DE1793611B2 (de) * | 1964-12-15 | 1973-06-07 | Merck Patent Gmbh, 6100 Darmstadt | 4,4-diphenylcyclohexylamine, ihre saeureadditionssalze und quartaeren ammoniumsalze |
AT273065B (de) * | 1964-12-15 | 1969-07-25 | Merck Ag E | Verfahren zur Herstellung neuer Säureadditionssalze von 4,4-Diphenyl-cyclohexylaminen |
GB1051280A (de) * | 1964-12-15 | |||
US3479352A (en) * | 1966-05-23 | 1969-11-18 | Monsanto Co | Trichloromethyl-tertiary amino substituted cycloalkenes and their preparation |
NL7207811A (de) * | 1971-06-11 | 1972-12-13 | ||
US4141993A (en) * | 1971-06-11 | 1979-02-27 | Astra Lakemedel Aktiebolaget | Compounds of diphenylcyclopentylamine type and methods for their preparation |
JPS608606B2 (ja) * | 1975-07-02 | 1985-03-04 | 富士写真フイルム株式会社 | 強磁性粉末の製法 |
SE7703427L (sv) | 1977-03-25 | 1978-09-26 | Astra Laekemedel Ab | Nya cykloalkylaminer |
JPS57144247A (en) * | 1981-03-02 | 1982-09-06 | Lion Corp | Preparation of n-substituted amino-alcohol compound |
JPS6354351A (ja) * | 1986-08-25 | 1988-03-08 | Kanegafuchi Chem Ind Co Ltd | 光学活性1−メチル−3−フエニルプロピルアジド及びその化合物を用いる光学活性アミンの製造法 |
-
1991
- 1991-03-06 DE DE69120699T patent/DE69120699T2/de not_active Expired - Fee Related
- 1991-03-06 EP EP91103350A patent/EP0445749B1/de not_active Expired - Lifetime
- 1991-03-06 IE IE075291A patent/IE910752A1/en unknown
- 1991-03-06 AT AT91103350T patent/ATE140213T1/de not_active IP Right Cessation
- 1991-03-07 CA CA002037721A patent/CA2037721A1/en not_active Abandoned
- 1991-03-07 JP JP3154155A patent/JPH0819058B2/ja not_active Expired - Lifetime
- 1991-03-07 NO NO910904A patent/NO175679C/no unknown
- 1991-03-07 KR KR1019910003622A patent/KR910016691A/ko not_active Application Discontinuation
- 1991-03-07 FI FI911138A patent/FI911138A/fi not_active Application Discontinuation
- 1991-03-07 CN CN91101218A patent/CN1054586A/zh active Pending
- 1991-03-07 US US07/665,669 patent/US5256824A/en not_active Expired - Fee Related
- 1991-03-07 HU HU91748A patent/HUT60710A/hu unknown
- 1991-03-07 AU AU72662/91A patent/AU645062B2/en not_active Ceased
- 1991-03-07 PT PT96967A patent/PT96967A/pt not_active Application Discontinuation
-
1995
- 1995-06-22 HU HU95P/P00345P patent/HU211519A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
IE910752A1 (en) | 1991-09-11 |
HUT60710A (en) | 1992-10-28 |
KR910016691A (ko) | 1991-11-05 |
EP0445749A1 (de) | 1991-09-11 |
DE69120699T2 (de) | 1997-01-09 |
EP0445749B1 (de) | 1996-07-10 |
NO175679B (no) | 1994-08-08 |
NO910904L (no) | 1991-09-09 |
DE69120699D1 (de) | 1996-08-14 |
NO910904D0 (no) | 1991-03-07 |
JPH0819058B2 (ja) | 1996-02-28 |
AU7266291A (en) | 1991-09-12 |
US5256824A (en) | 1993-10-26 |
JPH04234832A (ja) | 1992-08-24 |
HU211519A9 (en) | 1995-11-28 |
NO175679C (no) | 1994-11-16 |
PT96967A (pt) | 1991-10-31 |
FI911138A (fi) | 1991-09-09 |
AU645062B2 (en) | 1994-01-06 |
FI911138A0 (fi) | 1991-03-07 |
HU910748D0 (en) | 1991-09-30 |
CN1054586A (zh) | 1991-09-18 |
CA2037721A1 (en) | 1991-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE25974T1 (de) | Acyl-substituierte derivate von 1,2,3,4tetrahydroisochinolin-3-carboxysaeuren, ihre salze, diese enthaltende arzneimittel und verfahren zu ihrer herstellung. | |
WO2000061568A3 (de) | Mit zuckerresten substituierte 1,4-benzothiazepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
ATE174920T1 (de) | Pyridothiadiazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
ATE36859T1 (de) | 4'-demethyl-4-epipodophyllotoxin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
ATE156829T1 (de) | Substituierte aminophosphonatderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
ATE140213T1 (de) | N-monosubstituierte cyclopentenylamine, ein verfahren zu ihrer herstellung, und ihre verwendung als medikament | |
ATE201024T1 (de) | Carbamatderivate von 4-amino-3-isoxazolidinonen und 3-amino-1-hydroxypyrrolidinon-2-onen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE69710909D1 (de) | Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
ATE172976T1 (de) | 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE3781879D1 (de) | Anthracyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
DE69227207D1 (de) | 1-Piperazinyl-2-butene und 2-butyne, Zwischenverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
ATE168692T1 (de) | 3-substituierte cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE68906519D1 (de) | Aryloxypropanolaminotetraline, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel. | |
ATE143957T1 (de) | Aminoalkylchomone, verfahren für ihre herstellung und die enthaltende pharmazeutische zusammensetzungen | |
ATE168371T1 (de) | 5-amino-5,6,7,8-tetrahydrochinoline und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE29713T1 (de) | Arphamenin und ihm verwandte verbindungen, ein verfahren zu ihrer herstellung und ihre verwendung als medikamente. | |
ATE40118T1 (de) | Benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel. | |
ATE173734T1 (de) | Heteroarenylpiperazine, verfahren zu ihrer herstellung und ihre anwendung als medikamente | |
ATE43586T1 (de) | Arphameninderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
DE69229017D1 (de) | Glyceraldehyd-3-pentanid und Verfahren zu ihrer Herstellung | |
ATE140216T1 (de) | (cyclohexyl)alkenderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
AU659738B2 (en) | New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them | |
DE68904868D1 (de) | S-difluoromethylhomocysteine, verfahren zu ihrer herstellung und insektizide zusammensetzungen. | |
ATE49003T1 (de) | Pregnane derivate, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen, die sie enthalten. | |
ATE3295T1 (de) | Clavulansaeure-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |